Capio Biosciences Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Capio Biosciences's estimated annual revenue is currently $775k per year.(i)
  • Capio Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Capio Biosciences has 5 Employees.(i)
  • Capio Biosciences grew their employee count by -17% last year.

Capio Biosciences's People

NameTitleEmail/Phone
1
co-founder/ProfessorReveal Email/Phone
2
Financial Manager MBA, CPAReveal Email/Phone
3
Senior Scientist IReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M1820%N/AN/A
#2
$1.9M1233%N/AN/A
#3
$1.1M70%N/AN/A
#4
$0.9M60%N/AN/A
#5
$5.2M670%$45.5MN/A
#6
$1.4M90%N/AN/A
#7
$1.6M100%N/AN/A
#8
$1.1M717%N/AN/A
#9
$13.5M87-17%N/AN/A
#10
$0.6M4-20%N/AN/A
Add Company

What Is Capio Biosciences?

Our Vision: To be the world’s leading liquid biopsy company providing valuable clinical information to improve patient outcomes. Founded in 2015 by cofounders Seungpyo Hong PhD (UW, Madison WI) and Andrew Wang MD (UNC, Chapel Hill NC), Capio Biosciences is a biotech start-up focused on delivering high-value oncology diagnostics that can help inform patient care decisions and improve outcomes. At Capio Biosciences we are currently developing an advanced platform called CapioCyte™ for the capture of circulating tumor cells (CTCs) from whole blood. By utilizing a combination of biomimetic cell rolling and dendrimer-mediated multivalent cell capture, CapioCyte delivers significantly greater capture sensitivity than other platforms currently available. It is also able to provide enriched CTCs for post capture molecular analysis such as FISH, RNA-Seq and NGS. CapioCyte is therefore an excellent tool for today’s cancer research needs, and potentially for clinical patient management in the future.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$775k

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M5-37%N/A
#2
$0.5M525%N/A
#3
$0.4M50%N/A
#4
$0.4M50%N/A
#5
$0.4M50%N/A